Login

Dicerna Pharmaceuticals Inc 3 SEC Filings

Filed On Filing
16 Sep 2020 Form 3: Zeng Ling, Chief Legal Officer & Sec'y

No securities owned

09 Sep 2020 Form 3: Aradhye Shreeram, EVP & Chief Medical Officer

No securities owned

15 Jun 2020 Form 3: Paglia Regina M., Chief Human Resources Officer
02 Jun 2020 Form 3: Pagan Douglas W., Chief Financial Officer

No securities owned

11 Feb 2020 Form 3: Doberstein Stephen K, Director

No securities owned

19 Sep 2019 Form 3: Gray Patrick M., Director

No securities owned

07 Jun 2019 Form 3: Ciappenelli Robert D., Chief Commercial Officer

No securities owned

25 Jan 2019 Form 3: Kozin Marc D, Director

Holds 5,000 shares of Common Stock

25 Jan 2019 Form 3: Protopapas Anna, Director

No securities owned

15 Aug 2018 Form 3: Buchi J Kevin, Director

No securities owned

15 Aug 2018 Form 3: Smith Cynthia, Director

No securities owned

26 Jun 2018 Form 3: Wise Bart W, SVP, Legal Affairs

Holds 5,647 shares of Common Stock

16 Jun 2017 Form 3: Rosskamp Ralf, Chief Medical Officer

No securities owned

13 Apr 2017 Form 3: Bain Capital Life Sciences Investors, Llc, 10% owner and 5 others
15 Jun 2016 Form 3: Freed Martin I, Director

No securities owned

11 Jan 2016 Form 3: Green John B, Interim CFO

No securities owned

16 Dec 2014 Form 3: Ashburn Theodore, See Remarks

Holds 0 shares of No securities are beneficially owned

11 Dec 2014 Form 3: Peacock Bruce, Director

No securities owned

03 Apr 2014 Form 3: Bhargava Pankaj, Chief Medical Officer

Holds 0 shares of No securities are beneficially owned

04 Feb 2014 Form 3: Brookside Capital Management Llc, 10% owner and 4 others

Holds 2,337,000 shares of Common Stock

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support